BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balavoine F, Malabre P, Alleaume T, Rey A, Cherfils V, Jeanneton O, Seigneurin-Venin S, Revah F. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Bioorg Med Chem Lett 2007;17:3754-9. [PMID: 17448659 DOI: 10.1016/j.bmcl.2007.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Konnert L, Lamaty F, Martinez J, Colacino E. Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. Chem Rev 2017;117:13757-809. [PMID: 28644621 DOI: 10.1021/acs.chemrev.7b00067] [Cited by in Crossref: 77] [Cited by in F6Publishing: 41] [Article Influence: 15.4] [Reference Citation Analysis]
2 Macneil DJ. The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front Endocrinol (Lausanne) 2013;4:49. [PMID: 23626585 DOI: 10.3389/fendo.2013.00049] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
3 Lin H, Sassano MF, Roth BL, Shoichet BK. A pharmacological organization of G protein-coupled receptors. Nat Methods 2013;10:140-6. [PMID: 23291723 DOI: 10.1038/nmeth.2324] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
4 Pittalà V, Siracusa MA, Modica MN, Salerno L, Pedretti A, Vistoli G, Cagnotto A, Mennini T, Romeo G. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors. Bioorganic & Medicinal Chemistry 2011;19:5260-76. [DOI: 10.1016/j.bmc.2011.06.043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
5 Oyarzabal J, Howe T, Alcazar J, Andrés JI, Alvarez RM, Dautzenberg F, Iturrino L, Martínez S, Van der Linden I. Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists. J Med Chem 2009;52:2076-89. [DOI: 10.1021/jm8016199] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sumoto K, Fujisaki F, Shoji K. A Synthetic Application of β-Aminoalanines to Some New 5-Dialkylaminomethyl-3-phenylhydantoin Derivatives. HETEROCYCLES 2009;78:213. [DOI: 10.3987/com-08-11519] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Payen O, Top S, Vessières A, Brulé E, Plamont MA, McGlinchey MJ, Müller-Bunz H, Jaouen G. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide. J Med Chem 2008;51:1791-9. [PMID: 18303829 DOI: 10.1021/jm701264d] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
8 Kashif MK, Hussain A, Khawar Rauf M, Ebihara M, Hameed S. 5-(4-Fluoro-phen-yl)-5-methyl-imidazolidine-2,4-dione. Acta Crystallogr Sect E Struct Rep Online 2008;64:o444. [PMID: 21201471 DOI: 10.1107/S1600536807067803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]